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THE LEUCOPLAKIC VULVA 
Premalignant Determinants 
C. PAUL HODGKINSON, M.D.,* ROY B . P. PATTON, M.D., 
AND M . A . AYERS, M.D.* 
I N A PAPER proposing to discuss the leucoplakic vulva and any predisposing ten-
dency it may have to the development of squamous cell carcinoma, the term "pre-
malignant" has presumptuous connotations. This is presumptuous because it implies 
that more is known about cancer and its mode of development than can be supported 
by facts. What happens in the cell prior to the stage of carcinoma-in-situ is a 
burning and unsolved question in cancer research. How to detect and appraise the 
parameters of malignant potential is the essence of meaning connoted by the word 
"premalignant". 
With these limitations fully in mind, it is proposed in this discussion to reap-
praise the "white spot" diseases of the vulva for premalignant determinants. The 
basis for the report comes from a conjoined effort by the departments of gynecology-
obstetrics and pathology to reevaluate the clinical findings and the cellular pathology 
of these hyperkeratinizing diseases. The project was undertaken with hopes to clarify 
the terms of the dermatologist, the definitions of the pathologist, and the confusion 
and bewilderment of the gynecologist, respectively. 
In scope the subject matter is limited to the dystrophic changes in vulvar skin 
which are known, or have been suspected, to predispose to squamous cell carcinoma. 
Omitted from consideration are the rarer forms of malignancy, i.e., sarcoma, melano-
carcinoma, Paget's disease, basal cell carcinoma, and adenocarcinoma of Bartholin 
gland. Also eliminated from direct discussion are Bowen's disease and intraepithelial 
carcinoma (carcinoma-in-situ) because these conditions represent established malig-
nancy, not premalignancy. 
Definition of Terms 
Premalignancy may be defined as the internal, external, and temporal environ-
ment which precedes and predisposes the development of malignant changes in cells. 
* Department of Gynecology and Obstetrics 
**Department of Pathology 
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The premalignant lesion must have a identifiable degree of similarity to its malignant 
counterpart. By definition, the lesion must be reversible in its tendency to become 
malignant and, if completely removed, it must not recur as malignancy. I f left un-
disturbed a premalignant lesion will eventually become malignant, according to a 
predictable rate of incidence which is peculiar to conditions inherent to that organ. 
At this time scientific advancement has not reached the point that these qualifi-
cations can be met for cancer of any type. Coming closest are some of the border-
line stages of carcinoma-in-situ. However, not enough is known about cellular be-
havior to obtain consistent results. Perhaps improved supravital staining methods, 
more comprehensive tissue enzyme studies, and superior microscopic morphologic 
technics will be available eventually to solve this problem. 
This limitation in basic knowledge places a primary and major handicap upon 
the scientific worth of this study. With no recourse to precisely defined parameters 
of malignant potential, results must be equated indirectly through the use of crude 
and inaccurate end-points, such as rates of cancer occurrence. 
Morphopathology 
Skin is a compound organ that has a dual embryology: The epidermis arises 
from the ectoderm; the dermis from the mesoderm. Dividing the two components is 
the basement membrane upon which lies the basal layer of the epidermis. Next out-
wardly comes the multirowed prickle cells, then the thin granular layer, and finally 
the horny or keratin layer. Deep to the basement membrane is the dermis which is 
composed of 90 per cent collagen fibers which are interwoven with elastic fibers. 
The demis also contains blood vessels, lymphatics, tactile sensory organs, and the 
basement-membrane covered epidermal appendages: hair follicles, sebaceous glands, 
apocrine glands, and eccrine glands. 
In serving its sexual reproductive functions, the skin of the vulva is subjected to 
uncommon degrees of physical and chemical trauma. The growth and character of 
the skin of the vulva is under the influence of the adrenal and ovarian hormones; 
consequently, it goes through major changes during puberty and menopause. 
In this discussion the foci of interest are (1) the horny or keratin layer and (2) 
the prickle cell layer. The pathology of leucoplakia, the "white spot" is hypertrophy 
of the homy layer or hyperkeratinization; it may be a physiopathologic expression of 
stimulated growth of the underlying cefl layers or it may indicate over-retention and 
accumulation of keratin with atrophy of the underlying cells. 
Leucoplakia, kraurosis, and lichen sclerosus vel atrophicus constitute a triad of 
"white spot" diseases of the vulva. As signals of premalignancy, they will be con-
sidered first for their historical interest; then an effort will be made to place them in 
current knowledge of histopathology. 
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HISTORICAL 
Leucoplakia: according to Parrott and Miller' the word "leucoplakia" was 
coined by Schwimmer (1877) to describe a white plaque on the buccal mucosa. 
Morris (1882) applied the term white spots on the vulva. As first described, the word 
was intended for macroscopic description and was derived from "leucos" meaning 
white and "places" meaning flat plaque. 
Confusion over the term "leucoplakia" arose when it was appreciated that the 
lesion was often associated with malignancy. Research was stimulated and a number 
of investigators tried to classify the lesion histologically. In 1908 Bonney' clarified 
the histopathology and stated that "leucoplakia" and leucoplakic "vulvitis" were dif-
ferent stages of the same disease. Bonney'-^ identified leucoplakia vulvitis as a three-
stage disease: 1. early or hypertrophic, 2. intermediate or mixed, and 3. late or 
atrophic. Berkeley and Bonney" (1909) recognized that luecoplakia was a progres-
sive disease and they diflerentiated between "kraurosis" and "leucoplakic vulvitis,,. 
Langley, Hertig ,and Van Smith' (1951) attempted to define the histopathology 
similar to the stages of Bonney. In the early stage, the epithelium showed keratini-
zation and hypertrophy and thickened rete pegs which reached deeply into the corium. 
The late stage showed atrophy of the epithelium, excess keratinization, and absent 
or short pegs. The intermediate stage showed characteristics of both the early and late 
stages. The changes in the corium in all epithelial stages were characterized by atro-
phy, decrease in elastic fibers and replacement by collagen fibers, decrease in hair 
follicles and glands, round cell infiltration, and decrease in the number of blood 
vessels. 
It was soon evident that efforts to qualify histopathology of leucoplakia only 
compounded the enigma. Hyperkeratosis was the only common finding in all stages. 
This has put the problem back to the clinician because the common pathologic fea-
ture of the "white spot" was hyperkesatosis. As the result, the clinician has claimed 
it to be a pathologic entity; the pathologist has claimed it to be a clinical lesion. 
Kraurosis: the second "white spot" disease of the vulva has been equally con-
troversial. Jeffcoate and Woodcock' stated that disagreement about kraurosis extended 
even to the name. Breisky (1885) according to Parrott and Miller used the term to 
indicate a peculiar shrinking of the vulva which differed from sunple senile atrophy. 
Hunt' considered kraurosis to be a clinical syndrome, not a pathologic entity, and 
Lever stated that, practically, it was identical to lichen sclerosus vel atrophicus. Most 
have agreed that kraurosis has no distinct histopathology. Berkeley and Bonney 
(1909) claimed that kraurosis never predisposed to malignancy and thus differed 
from leucoplakia. Taussig' differentiated between kraurosis and atrophic leucoplakia 
and agreed that the former did not predispose to malignancy. Today a strong feeling 
has developed that the term "kraurosis" had best be discarded because it has neither 
chnical nor pathologic preciseness. 
Lichen sclerosus vel atrophicus: the third "white spot" disease, is a derma-
tological syndrome. It appears over other parts of the body, involves women of all 
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ages, and tends to resolve spontaneously. Distinguishing features are the tendency for 
lichen sclerosus vel atrophicus to spread to the introitus where it causes stenosis and 
narrowing and the tendency for it to spread to the perianal areas. Microscopically, 
the lesion cannot be accurately differentiated from kraurosis. 
Current Status of "White Spot" Diseases 
In the United States, led by the strong convictions of Taussig', and in England by 
similar attitudes of Berkeley and Bonney'', that leucoplakia was premalignant, if not 
actually malignant, a few years ago vulvectomy became the order of the day for all 
patients with "white spot" disease of the vulva. Gradually this procedure has been 
given up because the high rate of recurrence of the disease was soon noted and be-
cause the predicted malignancy failed to occur. Today there is a trend to treat white 
keratinized lesions as "possibly" premalignant and biopsy is gradually replacing vul-
vectomy. 
However, for the most part, (he modern clinician remains as confused as ever 
about the concepts of the "white spot" disease. He is bewildered by the glib terms 
confidently used to describe vulvar lesions. Also hard-put-to, is the pathologist when 
he tries arbitrarily to fit the histopathology to a distinct pathologic or chnical entity. 
Jeffcoate and Woodcock^ and MacAfee', critically appraised the chronic vulval 
lesions in efforts to resolve the dilemma of the "white spot" diseases. They con-
cluded that the three diseases should be equated under a common designation because 
they all show the same basic pathology. Jeffcoate and Woodcock proposed the all-
embracing and noncommittal clinical title: "chronic epithelial dystrophy". MacAfee 
has endorsed this suggestion. Jeffcoate and Woodcock emphasized that the "patho-
logist equally should be untrammeled by the need to append precise dermatological 
nomenclature to his report — his factual description — should include an assessment 
of the activity and orderliness of the squamous epithelium." 
The feeling is rather general that leucoplakia is a relatively specific reaction to 
nonspecific stimuli. Also, opinions are rather strong that the tendency for leucoplakia 
to predispose to malignancy is an expression that is a part of a local and general field 
change; and, in that individual and in that local area, there is a tendency for malig-
nancy to develop in multiple foci. McKelvey'" stated that the incidence of vulvar can-
cer paralleled the age-specific index curve in Minnesota and that there was the statis-
tic probability that all females would develop cancer of the vulva if they survived 
sufficiently long. 
Current Project 
The project which forms the basis for this report was undertaken to determine 
if the older and possibly obsolete attitudes toward chronic lesions of the vulva could 
be revised. In an effort to up-date clinical handling, multiple biopsy was substituted 
for simple vulvectomy. Each biopsy site was identified with numbers on a "vulval 
map". The numbered specimens were placed in separate containers for identification 
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by the pathologist (R.B.P.). Skin samples were obtained from areas showing atrophy 
as well as hypertrophy because malignancy may occur in either. 
Pathologic interpretation has been made according to the principles of cellular 
pathology. Opinions as to what constitutes premalignant tendencies have been based 
upon prescribed and definite cellular features and not upon histomorphologic patterns 
previously identified with leucoplakia. 
Pseudo-epitheliomatous hyperplasia is an apt descriptive term used by patho-
logists to indicate a lesion that microscopically looks malignant at low power magnifi-
cation. Masses of hyperplastic prickle cells thicken the epidermis and extend deeply 
into the dermis. However, high power examination of these cells shows that they lack 
the typical nuclear and cytoplasmic features of a premalignant or malignant lesion 
(Figure 1). 
This type of reaction occurs in conjunction with ulcerative and scarring lesions, 
and it frenquently overlies granular cell myoblastoma and melanoma. Pseudo-epithe-
liomatous hyperplasia as well as epidermoid carcinoma can be produced experimen-
tally by the application of tars and lubricating oils. The two conditions occur clinically 
in "mule spinner's" and "chimney sweep's" cancer. According to Jeffcoate and Wood-
cock' lubricating oil was incriminated in the developmicnt of vulvar cancer when 
Gerrard (1932) showed that women operatives in the cotton and woolen mills in 
England who were exposed to oil-impregnated waste material of their trade, developed 
carcinoma of the vulva at twice the rate of women of corresponding ages who were 
employed in other trades. 
Thus, pseudo-epitheliomatous hyperplasia fulfils some of the requirements of a 
premaHgnant lesion but, as defined pathologically, it is neither malignant nor pre-
malignant. 
"Premalignant" as adopted for this study was defined by the following character-
istics: hyperkeratosis, acanthosis (prickle cell hyperplasia), irregular rete ridges and 
epithelial cell atypism, and dyskeratosis involving the lower portion of the epithelium 
(Figure 2). Epithelial cell atypism has been considered most important it is charac-
terized by cellular and nuclear variation in size and in staining reactions, by the ten-
dency to loss of polarity, and by irregular keratinization. 
On the other hand, carcinoma-in-situ consists of these same features but the 
epithelial atypism and dyskeratosis involves the full thickness of the epithelium. There 
is undifferentiation or lack of normal maturation of the entire thickness of the epithe-
lial layers (Figure 3). 
Instances of border-line microscopic findings have been observed. OccasionaUy 
encountered in the lower half of the epithelial thickness were changes suggestive of 
in-situ malignancy. The critical decision for the pathologist has been to differentiate 
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between "actual" and "tendency toward" malignancy. The diagnosis then became 
a matter of judgment. Only time, constant clinical observation, and repeated biopsy 
can finely settle the problem for those patients whose lesions have been diagnosed as 
premalignant. Those patients diagnosed as having in-situ carcinoma were subjected 
to wide simple vulvectomy. 
Currently we have adopted a double standard of pathology reporting for "white 
spot" lesions of the vulva. In addition to the historic leucoplakia-kraurosis-lichen 
sclerosus vel atrophicus classification, an effort has been made to qualify specimens 
according to premalignant features. Specimens are qualified according to the following 
"project diagnosis": 
1. "negative for premalignant features." 
2. "postive for premalignant features." 
3. "carcinoma, intraepithelial." 
4. "carcinoma, invasive." 
In a recent group of 22 consecutive patients a total of 76 biopsy specimens was 
obtained. One patient had 10 separate sites biopsied. A total of 37 diagnoses was 
obtained with up to 3 distinct lesions identified in the same patient. The lesions 
varied from leucoplakia to condylomata, and each specimen was additionally classified 
according to project standards. The average number of biopsies per patient was 3.5, 
and the average number of diagnoses per patient was 1.7. 
Because this project has been in progress for only about 2 years, only a pre-
liminary report of the results can be made at this time. Selected reports of interesting 
cases illustrate the more important observations which have been made. The im-
portance of obtaining multiple biopsy specimens is evident in the following case 
reports. 
CASE REPORTS 
CASE 1 — Hyperkeratosis and prickle cell hyperplasia. (I.W.) Age 63, multipara, symptoms 
of vulvar irration of 2 weeks duration. 
Clinical examination: Entire vulva involved with scaly, leucoplakic changes, and with 2 
areas of ulceration. 
Treatment: 10 biopsy specimens. 
Pathologic final diagnosis: 1. Lichen sclerosus vel atrophicus (3 specimens). 2. Leucop-
lakia with hyperplasia and chronic inflammation (4 specimens). 3. Kraurosis, epithelial 
atrophy and chronic inflammation (3 specimens). 
Project diagnosis: Positive for premalignant features (4/10 specimens). 
CASE 2 -— Hyperkeratosis and prickle cell atrophy — Leucokeratosis: (B.R.) Age 57, para 
2, complained of itching, burning and pain of vulva for 10 years duration. 
Clinical examination: Leucoplakia, excoriation, thickened skin involving vulva and perianal 
areas. 
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Treatment: 1 biopsy specimens. 
Pathologic final diagnosis^ 1. Leucoplakia (4 specimens). 2. Leucokeratosis (1 specimen). 
3. Psoriaform dermatitis (2 specimens). 
Project diagnosis: Positive for premalignant features (4/7 specimens). 
CASE 3 — Pseudo-epitheliomatous hyperplasia. (J.V.) Age 72, para 2, with past history 
of carcinoma of breast 9 years previously, complained of irration of vulva for many years 
and a slight bloody vaginal discharge of one week duration. 
Clinical examination: Erythematous, scaly, thin, shiny skin of vulva with areas of leuco-
plakia. Cervis hard but not ulcerated. 
Treatment: 8 biopsy specimens of vulva and biopsy of cervix. 
Pathologic final diagnosis: 1. Cervix, squamous cell carcinoma staged clinically as inter-
national I A. 2. Vulva, pseudo-epitheliomatous hyperplasia. 
Project diagnosis: Possibly positive for premalignant features (0/8 specimens). 
CASE 4 — Carcinoma-in-Situ vulva. (M.M. ) Age 62, para 2. 
Clinical examination: Ulcerated, whitened left labia. 
Treatment: Biopsy of vulva — 6 specimens. 
Pathologic final diagnosis: Intraepithelial carcinoma, vulva. 
Project diagnosis: Carcinoma, intraepithelial (6/6 specimens). 
Figure 1 Figure 2 
Pseudoepitheliomatous hyperplasia, biopsy of (Case #2) Premalignant leukoplakia. There is 
vulva. Epithelium is hyperplastic and matura- irregular maturation of cells with retention of 
tion is proceeding normally. The large mass of nuclei in the keratin layer. Atypical cells in the 
hyperplastic squamous cells in lower half was basal layer are seen in the lower midportion 
in continuity with surface epithelium. (AU and on the left, 
figures at 325x and from hematoxylin and eosin 
stained sections.) 
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Figure 3 
(Case #4) Carcinoma in situ. There is nearly 
complete absence of differentiation throughout 
the entire thickness of the epithelium. 
Figure 4 
Epithelial hyperplasia, biopsy of vulva. Hyper-
keratosis and hyperplasia of prickle cell layer are 
present. There is no disturbance of maturation. 
g - -^e f-^ ih\ 
Figure 5 
(Case 1.) Kraurosis. A thick keratin layer is present. Epithelial layer is atrophic and 
are not evident. Subepithelial collagen is sparsely cellular and edematous. 
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PRELIMINARY CONCLUSIONS 
1. During the 2 years this project has been under study 42 patients have been 
observed. 
2. The futility of trying to segregate "white-spot" lesions of the vulva according 
to distinct clinical categories has been amply demonstrated. 
3. Information of high practical value has come from evaluating these lesions 
according to impressions of pathologic cell activity. 
4. The importance of procuring multiple biopsy specimens according to general 
field distribution of the lesion rather than upon impressions of maximum 
clinical activity, appears to have been well supported. 
5. While the preliminary results of this project do not permit the stating of a 
histopathologic definition of "premalignancy", it appears wise that a stand 
be taken on an arbitrary set of standards which can be subjected to the tests 
of time and experience. 
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